Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
DuPont, Herbert L
2014.
Challenges and opportunities in the management ofClostridium difficileinfection.
Expert Review of Gastroenterology & Hepatology,
Vol. 8,
Issue. 8,
p.
863.
Bissonnette, Luc
and
Bergeron, Michel G.
2015.
Current and Emerging Technologies for the Diagnosis of Microbial Infections.
Vol. 42,
Issue. ,
p.
87.
Zacharioudakis, Ioannis M
Zervou, Fainareti N
Pliakos, Elina Eleftheria
Ziakas, Panayiotis D
and
Mylonakis, Eleftherios
2015.
Colonization With Toxinogenic C. difficile Upon Hospital Admission, and Risk of Infection: A Systematic Review and Meta-Analysis.
American Journal of Gastroenterology,
Vol. 110,
Issue. 3,
p.
381.
Longo, Dan L.
Leffler, Daniel A.
and
Lamont, J. Thomas
2015.
Clostridium difficile Infection.
New England Journal of Medicine,
Vol. 372,
Issue. 16,
p.
1539.
Aldrete, Sol del Mar
Magee, Matthew J.
Friedman-Moraco, Rachel J.
Chan, Austin W.
Banks, Grier G.
Burd, Eileen M.
and
Kraft, Colleen S.
2015.
Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized Patients.
American Journal of Clinical Pathology,
Vol. 143,
Issue. 6,
p.
895.
Erb, S.
Frei, R.
Strandén, A.M.
Dangel, M.
Tschudin-Sutter, S.
and
Widmer, A.F.
2015.
Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
Clinical Microbiology and Infection,
Vol. 21,
Issue. 11,
p.
998.e9.
Ziakas, Panayiotis D.
Zacharioudakis, Ioannis M.
Zervou, Fainareti N.
Grigoras, Christos
Pliakos, Elina Eleftheria
Mylonakis, Eleftherios
and
Deshpande, Abhishek
2015.
Asymptomatic Carriers of Toxigenic C. difficile in Long-Term Care Facilities: A Meta-Analysis of Prevalence and Risk Factors.
PLOS ONE,
Vol. 10,
Issue. 2,
p.
e0117195.
Gilligan, Peter H.
2015.
Optimizing the Laboratory Diagnosis of Clostridium difficile Infection.
Clinics in Laboratory Medicine,
Vol. 35,
Issue. 2,
p.
299.
Bartsch, Sarah M.
Umscheid, Craig A.
Nachamkin, Irving
Hamilton, Keith
and
Lee, Bruce Y.
2015.
Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection.
Clinical Microbiology and Infection,
Vol. 21,
Issue. 1,
p.
77.e1.
Song, Linan
Zhao, Mingwei
Duffy, David C.
Hansen, Joshua
Shields, Kelsey
Wungjiranirun, Manida
Chen, Xinhua
Xu, Hua
Leffler, Daniel A.
Sambol, Susan P.
Gerding, Dale N.
Kelly, Ciarán P.
Pollock, Nira R.
and
Patel, R.
2015.
Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool.
Journal of Clinical Microbiology,
Vol. 53,
Issue. 10,
p.
3204.
Lessa, Fernanda C.
Mu, Yi
Bamberg, Wendy M.
Beldavs, Zintars G.
Dumyati, Ghinwa K.
Dunn, John R.
Farley, Monica M.
Holzbauer, Stacy M.
Meek, James I.
Phipps, Erin C.
Wilson, Lucy E.
Winston, Lisa G.
Cohen, Jessica A.
Limbago, Brandi M.
Fridkin, Scott K.
Gerding, Dale N.
and
McDonald, L. Clifford
2015.
Burden ofClostridium difficileInfection in the United States.
New England Journal of Medicine,
Vol. 372,
Issue. 9,
p.
825.
Blakney, Rebekah
Yanke, Eric
Fink, Cory
Wigton, Robert
and
Safdar, Nasia
2015.
Optimizing diagnostic testing for Clostridium difficile: The perceptions of physicians and nurses on when to order testing for C difficile.
American Journal of Infection Control,
Vol. 43,
Issue. 8,
p.
889.
Kundrapu, Sirisha
Sunkesula, Venkata
Tomas, Myreen
and
Donskey, Curtis J.
2016.
Response to Prior and Fitzpatrick.
Infection Control & Hospital Epidemiology,
Vol. 37,
Issue. 3,
p.
362.
Ross, Caná L.
Spinler, Jennifer K.
and
Savidge, Tor C.
2016.
Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.
Anaerobe,
Vol. 41,
Issue. ,
p.
37.
Pollock, Nira R.
and
Kraft, C. S.
2016.
Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.
Journal of Clinical Microbiology,
Vol. 54,
Issue. 2,
p.
259.
2016.
Molecular Microbiology.
p.
185.
Hanania, Alexander
Jiang, Zhi-Dong
Smiley, Casey
Lasco, Todd
Garey, Kevin W.
and
DuPont, Herbert L.
2016.
Fecal Calprotectin in the Diagnosis of Clostridium difficile Infection.
Infectious Diseases in Clinical Practice,
Vol. 24,
Issue. 1,
p.
31.
Jackson, Melissa
Olefson, Sidney
Machan, Jason T.
and
Kelly, Colleen R.
2016.
A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection.
Journal of Clinical Gastroenterology,
Vol. 50,
Issue. 9,
p.
742.
Dhillon, Harvinder S.
Johnson, Gemma
Shannon, Mark
Greenwood, Christina
Roberts, Doug
and
Bustin, Stephen
2016.
Homogeneous and digital proximity ligation assays for the detection of Clostridium difficile toxins A and B.
Biomolecular Detection and Quantification,
Vol. 10,
Issue. ,
p.
2.
Nicholson, Maribeth R.
Van Horn, Gerald T.
Tang, Yi-Wei
Vinjé, Jan
Payne, Daniel C.
Edwards, Kathryn M.
and
Chappell, James D.
2016.
Using Multiplex Molecular Testing to Determine the Etiology of Acute Gastroenteritis in Children.
The Journal of Pediatrics,
Vol. 176,
Issue. ,
p.
50.